Last reviewed · How we verify

Hippuran I131 — Competitive Intelligence Brief

Hippuran I131 (iodohippurate sodium I131) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: iodohippurate sodium I131. Area: Nephrology.

unknown iodohippurate sodium I131 Nephrology Live · refreshed every 30 min

Target snapshot

Hippuran I131 (iodohippurate sodium I131). Hippuran I131 works by being taken up by the kidneys and excreted in the urine, allowing for imaging of the renal function.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Hippuran I131 TARGET iodohippurate sodium I131 unknown iodohippurate sodium I131

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (iodohippurate sodium I131 class)

  1. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Hippuran I131 — Competitive Intelligence Brief. https://druglandscape.com/ci/iodohippurate-sodium-i131. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing